• 제목/요약/키워드: I-131

검색결과 1,085건 처리시간 0.027초

방사성동위원소옥소(放射性同位元素沃素)($^{131}I$)가 "마우스"의 주요장기(主要臟器)의 병리조직상(病理組織像)에 미치는 영향(影響)에 관(關)한 연구(硏究) (Histopathological Studies of Mice after Administration of Radioactive Iodine($^{131}I$))

  • 노재성;이문호
    • 대한핵의학회지
    • /
    • 제1권2호
    • /
    • pp.85-97
    • /
    • 1967
  • Histopathological changes of various organs of the mice after intra-peritoneal injections of radioactive iodine ($^{131}I$) were experimentally observed. Sixity healthy female mice, weighing average 25 gm, devided into 6 groups, were used. The various doses of $^{131}I$ were injected intraperitoneally at different intervals. The histopathological changes after these treatments were observed in organs such as thyroids, parathyroids, livers, kidneys and gonads. Following were the results; 1) Thyroid: In the group A given $^{131}I$ with a single dose of $10{\mu}C$ per gm body weight, it was observed that the protoplasms of follicular epithelial cells were destroyed, the nuclei were expanded or dissoluted, showing pyknotic changes of nuclei and vacuolizations of protoplasms. In the group B given $^{131}I$ with a single dose of $5{\mu}C$ per gm body weight, hyperemias, hemorrhages and hyaline degenerations in the whole area were observed. In the group C given $^{131}I$ with 3 doses of $2.5{\mu}C$ per gm body weight every week, the thyroid parenchyms were destroyed and epithelial cells of varing size were observed in the fibrinous tissues. In the group D given $^{131}I$ with 6 doses of $0.5{\mu}C$ per gm body weight every week, some destroyed follicles and new borne follicles were observed. But the histopathological changes resemble the follicles of the normal thyroid gland. In the group E and F given $^{131}I$ with 8 and 10 doses of $0.2{\mu}C\;and\;0.01{\mu}C$ for each group per gm body weight every two days, both pyknotic changes of nuclei and cytoplasmic vacuolizations of the follicular epithelia, hypertrophies of follicles and abnormal irregular follicular structures were observed, and in the group F, lymphocytes appeared around the thyroid glands. 2) Parathyroid: In the group A, hyperemia, proliferations of connective tissues, karyorrhexes and vacuolizations were observed. In other experimental groups, no particular pathological change was observed. 3) Liver: The degnerative changes and acute or chronic inflammatory changes were observed in proportion to the amount of $^{131}I$ injected. Atrophies of the liver cells, dilatations of sinusoids, hyaline degenerations and necrotic pictures were observed. 4) Kidney: In the group A, congestions and infiltrations of mononuclear cells and granulocytes were observed around the cortical arteries, and in the group B, the degenerative changes of cortexes, and, in the group C and D, hydronephrotic changes were observed respectively, and hyaline degenerations were partially observed. 5) Gonad: In the group A, the follicles were degenerated. The ova in the follicles showed irregular figures. The changes in the group B were almost the same as in the group A, but the changes were mild. In the group C, the destructions of whole ova, the hypertrophies of ovarian follicular membranes and pyknotic changes of nuclei were observed. In the group D, the pathological changes were similar to that of group C, but mild in the grade. In the group E, almost none of ovarian follicular fluid was observed, and in the group F, the tissue pictures were almost similar to that of the normal group.

  • PDF

전이성 분화 갑상선암에서 200mCi 방사성 옥소 치료효과 평가를 위한 혈청 Thyroglobulin 추적검사와 전신스캔의 의의 (Evaluation of Therapeutic Effect with Serum Thyroglobulin and Whole Body Scan after 200mCi $^{131}I$ Treatment in Patients with Well-Differentiated Thyroid Carcinoma)

  • 이창희;윤종길;정상훈;권교선;최창운;임상무;홍성운
    • 대한핵의학회지
    • /
    • 제29권4호
    • /
    • pp.451-459
    • /
    • 1995
  • Thirty-eight patients with metastatic well-differentiated thyroid carcinoma treated with 200mCi $^{131}I$ were studied. There were false negative serum thyroglobulin values during TSH suppression or at anti-thyroglobulin antibody(+) and discrepancies between findings of whole body scan and serum thyroglobulin level. After one to five cycles of 200mCi $^{131}I$ therapy, complete remission and partial remission were achieved at 5.3% and 57.9%, respectively. We concluded that all of serum thyroglobulin, TSH, anti-thyroglobulin antibody, $^{131}I$ or $^{123}I$ whole body scan were necessary in follow up of metastatic well-differentiated thyroid carcinoma. Also, if there was no response after repetitive 200mCi $^{131}I$ therapy, higher doses of $^{131}I$ therapy should be considered.

  • PDF

부신수실 영상용 $^{131}I$ 표지 메타요오도벤질구아니딘 $(^{131}I-MIBC)$의 제조에 관한 연구 (Studies on Preparation of $^{131}I$ Labelled m-Iodobenzylguanidine $(^{131}I-MIBG)$ for Adrenomedullary Imaging)

  • 박경배;오옥두;김재록
    • 대한핵의학회지
    • /
    • 제24권1호
    • /
    • pp.101-107
    • /
    • 1990
  • To develop $^{131}I-labelled$ m-iodobeneylguanidine $(^{131}I-MIBG)$, various experiments such as synthesis of MIBG, establishment of labelling conditions, determination of radiochemical purity, and examination of stability were carried out. 1) m-Iodobenzylguanidine (MIBG) sulfate was synthesized with a total yield of 62.4% by the condensation of m-iodobenzylamine hydrochloride with cyanamide via MIBG bicarbonate. Its physical properties, IR, $^1H-NMR$, and elemental analysis data were nearly identical to those of literature. 2) Freeze-dried or vacuum-dried kit vials were prepared from the mixture so as to contain MIBG (2 mg), ascorbic acid (10 mg), copper (II) sulfate (0.14 mg), and tin (II) sulfate (0.5 mg) per vial. Copper ( I ) catalyzed radioiodination of MIBG was carried out using kit vials and 0.01 M $H_2SO_4$ as solvent at $100^{\circ}C$ for 30 min under nitrogen atmosphere (optimal conditions). Labelling yield was 98% and radiochemical purity was 99.5%, respectively. 3) Solid-phase radioiodination of MIBG was carried out at $155^{\circ}C$ for 30 min using the prepared vials to contain MIBG (2 mg) and ammonium sulfate (10 mg). Duplicate reactions under the same conditions showed labelling yield of 95% and radiochemical purity of 99.5%. 4) $^{131}I-MIBG$ prepared either by catalytic or by solid-phase exchange method showed radio-chemical purity of 99% even after 3 days storing at room temperature.

  • PDF

흑색종에서의 I-131표지 혈관내피세포성장인자 수용체2항체를 이용한 방사면역치료 평가 (Evaluation of the Radioimmunotherapy Using I-131 labeled Vascular Endothelial Growth Factor Receptor2 Antibody in Melanoma Xenograft Murine Model)

  • 김은미;정환정;박은혜;정수진;이창문;장규윤;김동욱;임석태;손명희
    • Nuclear Medicine and Molecular Imaging
    • /
    • 제42권4호
    • /
    • pp.307-313
    • /
    • 2008
  • 목적: 혈관내피성장인자(VEGF)와 그 수용체는 종양의 성장과 전이에 매우 중요한 역할을 한다 3개의 수용체가 알려져 있는데 그 중에서도 VEGFR2 (Flk-1/KDR)가 종양 angiogenesis에 매우 밀접하게 관련한 것으로 알려져 있다. 본 연구에서는 마우스 Flk-1 항체로 알려진 DC101에 I-131을 표지하여 매우 공격적인 종양으로 알려진 흑색 종의 치료 정도를 확인해 보고자 하였다. 방법: 하이브리도마 세포에서 Flk-1 항체인 DC101을 분리하여 western blot, ELISA, maldi-tof 방법을 이용하여 순도를 확인하고 항체 에 chloramin T를 이용하여 I-131을 표지하였다. 누드마우스에 B16F10세포를 주사하여 흑색종 모델을 만들고 평균 $200-250\;mm^3$으로 키워 $^{131}I$-DC101을 주사하여 영상과 시간별 장기섭취율(%ID/g)을 비교하고, 종양내 Flk-1 발현을 확인하기 위하여 면역염색 등을 시행하였다. 흑색종 동물모델을 5개 군으로 나누어 각각 치료를 시행하였다. 1군은 PBS만을, 2군은 $^{131}I$-DC101 $50\;{\mu}g(200\;{\mu}Ci)$을, 3군은 DC101 $50\;{\mu}g$을, 4군은 $^{131}I$-DC101 $30\;{\mu}g(200\;{\mu}Ci)$을, 5군은 $^{131}I$-DC101 $15\;{\mu}g(200\;{\mu}Ci)$을 각각 매 3일 ${\sim}$ 4일마다 주사하고 전체 5회를 주사하였고 종양볼륨을 측정하였다. 결과: $^{131}I$-DC101을 흑색종 모델에 정맥주사하고 78시간까지 영상을 얻은 결과 시간에 따라 종양섭취가 증가 하는 영상을 보였다. 시간대별 장기섭취를 정확히 확인하기 위하여 1시간, 6시간, 24시간, 48시간, 72시간 장기섭취율을 비교한 결과 시간에 따라 혈액내 방사능치가 서서히 감소하였고 다른 장기의 섭취도 시간에 따라 감소하였고 종양의 섭취는 48시간까지 증가하였다가 그 이후는 감소하였다. 흑색종 동물모델에 $^{131}I$-DC101 치료를 시행한 결과 3번째 주사까지는 각군간의 유의한 차이를 보이지 않다가 4번째 주사를 시행한 때부터 1군과 2군, 또는 1군과 4군간의 유의한 차이를 보이기 시작했다. 또한 5번째 주사 이후에는 5군에서도 유의한 차이를 보여 I-131 에 의한 효과가 뚜렷해짐을 확인하였다. 결론 마우스 Flk-1 항체로 알려진 DC101을 흑색종 모델에 정맥내 주사하였을 때, 종양성장억제 효과를 보이지 않는 항체양에서도 I-131을 표지하여 치료를 시행했을 경우에는 효율적인 종양성장억제 효과를 보였다.

Mass Interception Fractions and Weathering Half-lives of Iodine-131 and Radiocesium in Leafy Vegetables Observed after the Fukushima Daiichi Nuclear Power Plant Accident

  • Tagami, Keiko;Uchida, Shigeo
    • Journal of Radiation Protection and Research
    • /
    • 제46권4호
    • /
    • pp.178-183
    • /
    • 2021
  • Background: This study was carried out to provide environmental transfer parameter values to estimate activity concentrations of these radionuclides in agricultural crops when direct contamination occurred. Materials and Methods: Mass interception fractions (FBs) and weathering half-lives (Tws) of 131I and radiocesium were calculated using openly available monitoring data obtained after the Fukushima Daiichi Nuclear Power Plant accident. FB is the ratio between the initial radioactivity concentration of a radionuclide retained by the edible part of the plant (Bq·kg-1 fresh weight [FW]) and the amount of deposited radionuclide in that area (Bq·m-2). Tw values can be calculated using activity concentrations of crops decreased with time after the initial contamination. Results and Discussion: Calculated FB and Tw values for 131I and radiocesium were mostly obtained for leafy vegetables. The analytical results showed that there was no difference of FBs between 131I and radiocesium by t-test; geometric mean values for leafy vegetables cultivated under outdoor conditions were 0.058 and 0.12 m2·kg-1 FW, respectively. Geometric mean Tw value of 131I in leafy vegetables grown under outdoor conditions was 8.6 days, and that of radiocesium was 6.6 days; there was no significant difference between Tw values of these radionuclides by Wilcoxon rank sum test. Conclusion: There was no difference between 131I and radiocesium for FBs and Tws. By using these factors, we would be able to carry out a rough estimation of the activity concentrations of 131I and radiocesium in the edible part of leafy crops when a nuclear accident occurred.

머신러닝 기반 고용량 I-131의 용량 예측 모델에 관한 연구 (A Study on Predictive Modeling of I-131 Radioactivity Based on Machine Learning)

  • 유연욱;이충운;김정수
    • 대한방사선기술학회지:방사선기술과학
    • /
    • 제46권2호
    • /
    • pp.131-139
    • /
    • 2023
  • High-dose I-131 used for the treatment of thyroid cancer causes localized exposure among radiology technologists handling it. There is a delay between the calibration date and when the dose of I-131 is administered to a patient. Therefore, it is necessary to directly measure the radioactivity of the administered dose using a dose calibrator. In this study, we attempted to apply machine learning modeling to measured external dose rates from shielded I-131 in order to predict their radioactivity. External dose rates were measured at 1 m, 0.3 m, and 0.1 m distances from a shielded container with the I-131, with a total of 868 sets of measurements taken. For the modeling process, we utilized the hold-out method to partition the data with a 7:3 ratio (609 for the training set:259 for the test set). For the machine learning algorithms, we chose linear regression, decision tree, random forest and XGBoost. To evaluate the models, we calculated root mean square error (RMSE), mean square error (MSE), and mean absolute error (MAE) to evaluate accuracy and R2 to evaluate explanatory power. Evaluation results are as follows. Linear regression (RMSE 268.15, MSE 71901.87, MAE 231.68, R2 0.92), decision tree (RMSE 108.89, MSE 11856.92, MAE 19.24, R2 0.99), random forest (RMSE 8.89, MSE 79.10, MAE 6.55, R2 0.99), XGBoost (RMSE 10.21, MSE 104.22, MAE 7.68, R2 0.99). The random forest model achieved the highest predictive ability. Improving the model's performance in the future is expected to contribute to lowering exposure among radiology technologists.

炭化水素內에서의 Alkyl Iodides의 光分解에서 $II^{131}$과 Alkyl Iodides 間의 交換反應 (Exchange Reaction Between Alkyl Iodides and $II^{131}$ in the Photolysis of Alkyl Iodides in Hydrocarbon)

  • 최재호
    • 대한화학회지
    • /
    • 제10권1호
    • /
    • pp.43-45
    • /
    • 1966
  • The rate of exchange of I atom between alkyl iodides(ethyl or methyl iodide) and $I_2$ in n-hexane have been determined using $II^{131}$. It is found that the escape of $CH_3$ radicals from a solvent cage is faster than $C_2H_5$ radicals and that photolysis of $C_2H_5I$ is almost identical to that in the case of $CH_3I$.

  • PDF

갑상선 재발암의 진단과 치료에 대한 고찰 (Diagnosis and Treatment of the Recurrent Thyroid Cancer)

  • 권오경;박성길;오성수
    • 대한두경부종양학회지
    • /
    • 제16권1호
    • /
    • pp.58-63
    • /
    • 2000
  • Objectives: To demonstrate effective diagnostic method and proper management of recurrent thyroid cancer through to compare treatment and surveillance of $I^{131}$ scanning detected recurrence and clinically detected recurrence. Material and Methods: We retrospectively analyzed clinical information about 46 patients who has recurrent thyroid cancer of 298 patients who have been primarily operated due to thyroid cancer in PMC at the over 10 years between 1986 and 1995. We examine incidence of recurrence due to pathologic types, site of recurrence, disease free interval, detection method of recurrence, and also treatment and progression of recurrence. A patients in which the clinical examination was entirely negative and the $I^{131}$ scan demonstrated either a new area of $I^{131}$ uptake or an increased area of concentration, compared to the previous scan, was designated as a recurrence detected by $I^{131}$ scan only. Recurrences that were obviously by physical examination or chest x-ray, etc were considered clinically detected recurrence, regardless of the the results of the thyroid scan. Results: Mean of disease tree interval(DFI) is 36months. When mean DFI of $I^{131}$ scan detected recurrence is 28months, whereas mean DFI of clinically detected recurrence is 47months. In statiscal analysis, p-value is 0.043 as significantly. In progression of recurrent patient, NED is 28case, AWD is Sease, DOD is 13case. Among the 13case, scan detected recurrence is lease of 20 patients(5%), whereas clinically detected recurrence is l2case of 26 patient(46%). In statiscal analysis, p-value is 0.003 as significantly. Conclusion: Early detection of the recurrent thyroid cancer by $I^{131}$ scanning leads to good progress compare with detection by clinical examination. NED: No Evidence of Disease AWD : Alive With Disease DOD : Dead Of Disease DOC: Dead of Other Cause

  • PDF

I-131 치료를 받은 분화갑상선암 환자에서 I-131의 유효반감기 (Effective Half-life of I-131 in Patients with Differentiated Thyroid Cancer Treated by Radioactive I-131)

  • 박석건
    • Nuclear Medicine and Molecular Imaging
    • /
    • 제42권6호
    • /
    • pp.464-468
    • /
    • 2008
  • 목적 : I-131 치료를 받는 분화갑상선압 환자에서 I-131의 유효반감기($T_{eff}$)는 투여량의 계산이나 격리치료의 기간을 결정하기 위해서는 알아야 할 값 중 하나이다. 그러나 $T_{eff}$를 계산하려면 자주 선량을 측정해야 하기 때문에 측정하는 사람의 방사선노출이 문제가 된다. 이런 이유로 아직 한국인에서 $T_{eff}$값은 찾기 어렵다. 측정하는 사람에 대한 방사선 노출 없이 연속적으로 선량 변화를 측정하고, 이로부터 $T_{eff}$와 48시간 체내잔류량, 1.1 GBq이하가 될 때까지의 시간을 계산하고자 하였다. 방법: 방사선 선량계의 탐침은 격리치료실 안의 벽에 고정하고, 선량계는 밖에서 읽도록 하는 간단한 방법을 사용하였다. 2006년 1월부터 12월까지 I-131 치료($3.7{\sim}7.4\;GBq$)를 받은 분화갑상선 환자 68명(여=55, 남=13, 연령=$47{\pm}13.7$)에서 격리치료실 입원 중 선량변화를 측정하였다. 이 값을 가지고 개인용 컴퓨터의 스프레드시트 프로그램을 사용하여 $T_{eff}$를 계산하였다. 모든 환자에서 혈중 크레아티닌 농도를 측정하였다. 결과: $T_{eff}$$15.4{\pm}4.3$ ($9.4{\sim}32.5$)시간이었다. $T_{eff}$는 혈중 크레아티닌이 증가할수록 길어지는 경향은 있었으나, 상관계수는 높지 않았다(r=0.45). 48시간 후 남은 양은 $4.9{\pm}4.2$ ($1{\sim}23$)%였다. 전신에 남은 양이 1.1GBq 이하가 될 때까지의 시간은, 9.25GBq를 투여한다고 가정했을 때에는 $47.1{\pm}13.2$시간, 7.4 GBq일 때 $42.1{\pm}11.9$시간, 5.55 GBq일 때 $35.7{\pm}10$시간, 3.7 GBq일 때 $26.7{\pm}7.5$시간으로 계산되었다. 결론: 선량계의 탐침과 몸체를 분리하는 간단한 방법으로 측정하는 사람의 방사선노출이 없이 격리치료실에 입원한 환자의 선량변화를 연속적으로 측정할 수 있었고, 유도된 곡선으로부터 $T_{eff}$를 계산했다. 이 값을 이용하여 48시간 체내잔류량과 투여한 양이 1.1 GBq 이하가 될 때까지의 시간을 계산하였다.

고용량 방사성옥소 치료를 받은 갑상선분화암 환자에서 Dual Time I-131 Whole Body Scan을 이용한 유효반감기의 측정 (Measurement of Effective Half-life Using Dual Time I-131 Whole Body Scan in Patients with Differentiated Thyroid Cancer Treated by High Dose Therapy)

  • 윤재식;이재곤;이기현;임광석;최학기;이상미
    • 핵의학기술
    • /
    • 제18권1호
    • /
    • pp.98-103
    • /
    • 2014
  • 갑상선 분화암 환자의 방사선 치료에서 I-131의 유효반감기는 환자에게 투여하는 양의 계산뿐만 아니라 환자의 격리 입원기간의 결정, 환자로부터 가족들이 받게 되는 선량을 계산하는데 유용한 값이다. 하지만 이 값은 물리적반감기와는 달리 실측을 해야만 얻을 수 있어 입원 격리중인 환자에게 계측하기가 기술적으로 어려운 문제가 있다. Dual time I-131 whole body scan의 초기촬영과 지연촬영 사이의 체내잔류방사능량을 이용하여 전신과 갑상선에 유효반감기를 추정해 보았다. 또한 혈중 크레아티닌 농도, GFR, 투여량이 유효반감기와 상관관계가 있는지 알아보았다. 유효반감기 측정을 위해 전신에 체내잔류방사능량과 갑상선의 잔류방사능량을 측정하기 위해 환자의 전신을 흥미영역으로 설정한 후 배후방사능을 보정하여 전신의 체내잔류방사능량을 획득하였고, 갑상선 부위에 ROI를 설정한 후 배후 방사능을 보정하여 갑상선의 잔류방사능량을 획득하였다. 초기영상과 지연영상의 측정값 사이의 비율을 계산하여 전신과 갑상선의 유효반감기를 구하였다. 또한 유효반감기와 GFR, 혈중크레아티닌 농도, I-131 투여량과의 상관관계를 분석하였다. 전신의 체내잔류방사능량을 측정한 값의 유효반감기는 $17.06{\pm}5.50$시간으로 나타났고 갑상선의 잔류방사능량을 측정한 값의 유효반감기는 $17.22{\pm}5.41$시간으로 나타났으며 두 유효반감기는 유의한 차이를 보이지 않았다(P=0.887). GFR 값이 올라갈수록 전신의 유효반감기(r=-0.407, P=0.003)와 갑상선 유효반감기(r=-0.473, P=0.001) 모두 유의하게 감소하였으며 혈중크레아티닌 농도가 올라갈수록 전신의 유효반감기(r=0.309, P=0.029)와 갑상선 유효반감기(r=0.371, P=0.008) 모두 유의하게 증가하였다. 투여량은 두유효반감기와 상관관계를 보이지 않았다. 본 연구를 통해 고용량 방사성요오드 치료환자 입원기간의 최적화 연구와 기존 유효반감기를 구하기 위해 종사자의 피폭 및 복잡성을 보완하여 간편하게 측정을 할 수 있을 것이라 생각한다. 또한 분석된 갑상선의 유효반감기를 적용한 MIRD schema의 내부피폭선량 평가 연구에도 활용할 수 있을 것으로 사료된다.

  • PDF